Copyright
©The Author(s) 2025.
World J Gastroenterol. May 28, 2025; 31(20): 105554
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.105554
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.105554
Figure 10 Changes in body weight, liver weight, and hepatosomatic index in mice treated with carbon tetrachloride and zebularine.
A: Body weight at 2, 4, and 6 weeks; B: Mouse liver mass-timed histograms for each group; C: Hepatosomatic index-timed histograms for each group (n = 12). aP < 0.05. bP < 0.01. dP < 0.0001. 1P vs control. 2P vs carbon tetrachloride. CCl4: Carbon tetrachloride.
- Citation: Lyu SY, Xiao W, Chen YJ, Liao QL, Cai YY, Yu C, Liu JY, Liu H, Zhang MP, Ren YL, Yu QL, Qi YM, Xiao EH, Luo YH. Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism. World J Gastroenterol 2025; 31(20): 105554
- URL: https://www.wjgnet.com/1007-9327/full/v31/i20/105554.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i20.105554